VRILIGY

What is VRILIGY?

VRILIGY is a medicinal product for men intended for the pharmacotherapy of premature ejaculation. The product contains dapoxetine in a dosage of 60 mg and belongs to selective short-acting serotonin reuptake inhibitors. The drug helps to increase the time to ejaculation and improve control over ejaculation. VRILIGY is not intended for continuous daily use without a specific prescription from a doctor.

The drug is usually available in the form of tablets for oral administration. This dosage form provides convenient dosing and relatively rapid absorption of the active substance. Dapoxetine quickly reaches therapeutic concentration and is then excreted from the body, which corresponds to on-demand use. The exact specifications of the packaging, tablet coating, and excipients should be checked in the instructions for the specific batch.

The manufacturer of VRILIGY is Centurion Laboratories, a pharmaceutical company that produces drugs of various therapeutic categories. The product belongs to the categories "For Men", "Prolongators" and "Dapoxetine 60 mg". The drug does not increase testosterone levels and is not a classic erection stimulant. Before starting administration, a consultation with a doctor is necessary, as premature ejaculation can have psychological, urological, endocrine, or neurological causes.

What is VRILIGY prescribed for?

The main indication for the use of VRILIGY is premature ejaculation in adult men. This condition is characterized by ejaculation occurring before the desired moment, insufficient control over ejaculation, and the associated emotional discomfort. To establish a diagnosis, not only the duration of sexual intercourse is important, but also the regularity of symptoms and their impact on the quality of life. It is impractical to evaluate the problem solely by the number of minutes on your own.

VRILIGY may be prescribed when premature ejaculation occurs during most sexual contacts and causes relationship strain, anxiety, or avoidance of intimacy. Dapoxetine helps to prolong the intravaginal ejaculatory latency time, which is the interval from the start of vaginal penetration to ejaculation. Treatment can also improve the subjective sense of control over the ejaculatory reflex. The result depends on the individual response of the body, concomitant diseases, and correct use.

The drug is not intended to increase sexual desire, treat infertility, or eliminate all forms of erectile dysfunction. If an unstable erection is observed at the same time, a separate medical evaluation and careful selection of combination therapy are required. The best result can be achieved by combining drug treatment with psychosexual counseling and behavioral techniques. VRILIGY must be prescribed by a doctor after clarifying the symptoms, medical history, and potential contraindications.

Composition and active components of VRILIGY

The active component of VRILIGY is dapoxetine 60 mg, usually presented in the form of dapoxetine hydrochloride salt in an equivalent amount. Dapoxetine temporarily inhibits the reuptake of serotonin by nerve cells. Serotonin is a neurotransmitter, a substance through which signals are transmitted between cells of the nervous system. Enhancing its action in certain nerve pathways contributes to the delay of the ejaculatory reflex and better control over ejaculation.

The tablet also contains excipients necessary for core formation, stability of the drug, disintegration, and coating. They do not provide the main therapeutic effect, but they can be important for people with intolerance to individual substances. The exact list of fillers, colorants, and coating components must be checked with the official instructions and packaging labeling. In case of allergy to dapoxetine or any excipient, administration is contraindicated.

Dosage of VRILIGY

The standard starting dose of dapoxetine for adult men is usually 30 mg approximately one to three hours before anticipated sexual contact. Since one tablet of VRILIGY contains 60 mg, it should not be used as a starting dose without a doctor's prescription. The 60 mg dose is considered only when 30 mg is not sufficiently effective, is well tolerated, and does not cause significant adverse reactions. The decision to increase the dose is made by a doctor after evaluating the benefit-risk ratio.

VRILIGY is taken no more than once within 24 hours and only as needed. The drug is not intended for a continuous daily course unless a different regimen is specifically determined by a doctor. The advisability of continuing therapy is evaluated after the first few doses and periodically thereafter, taking into account efficacy, tolerability, and frequency of sexual contacts. Increasing the dose on your own does not guarantee a stronger effect, but increases the risk of dizziness, nausea, drop in blood pressure, and fainting.

Regimen adjustment may be required in case of liver or kidney diseases, cardiovascular disorders, or concomitant use of other drugs. Splitting the tablet is permissible only when provided for by its design and confirmed by the manufacturer's instructions. A tablet without a functional score line should not be used to obtain an exact half dose. Before taking VRILIGY 60 mg, it is necessary to inform the doctor about all chronic diseases and medications, including over-the-counter drugs and herbal supplements.

How to take VRILIGY correctly?

The VRILIGY tablet is swallowed whole with a full glass of water, approximately one to three hours before sexual activity. A sufficient amount of fluid helps reduce the likelihood of dehydration and orthostatic reaction — a sharp drop in blood pressure when standing up. The drug can be taken regardless of food intake, although a very heavy or fatty meal can slightly delay the onset of action. Do not chew or crush the tablet unless otherwise specified in the official instructions.

Since the drug is used as needed, the concept of a missed dose usually has no practical significance. Do not take a double dose or use a tablet after sexual contact to compensate for a missed one. The next administration is possible only if necessary and no earlier than after 24 hours. If dizziness, weakness, darkening in the eyes, or nausea occur after administration, you should immediately sit or lie down, preferably so that the head is lower than the torso.

Before the first use, a consultation with a doctor is required, with an evaluation of blood pressure, heart rate, and the risk of fainting. It is necessary to avoid dehydration, overheating, prolonged standing, and rising sharply from a bed or chair. You should not take VRILIGY "for prevention" if the diagnosis of premature ejaculation is not confirmed. The individual response of the body may vary, so the speed of onset and intensity of the effect are not the same for all men.

Side effects of VRILIGY

The most common side effects of dapoxetine include nausea, headache, dizziness, diarrhea, dry mouth, and insomnia. Fatigue, anxiety, increased sweating, decreased concentration, and abdominal discomfort are possible. The frequency and severity of adverse events may increase with the 60 mg dose. Most mild reactions are temporary, but their recurrence should be reported to a doctor.

Palpitations, blood pressure fluctuations, visual impairment, somnolence, tremor, or decreased libido occur uncommonly. A rare but important reaction is syncope (fainting), especially within the first hours after administration. The risk increases with dehydration, alcohol consumption, standing up quickly, or combining with drugs that lower blood pressure. In case of a pre-syncope state, it is necessary to stop activity, sit or lie down, and ensure access to fresh air.

Immediate medical attention is required in case of loss of consciousness, seizures, severe chest pain, pronounced palpitations, difficulty breathing, or signs of allergy. Sudden mood changes, suicidal thoughts, severe agitation, confusion, high fever, and muscle rigidity are also dangerous. The latter group of symptoms may indicate serotonin syndrome — excessive activity of serotonin, especially in case of incompatible drug combinations. Any unusual reaction requires an individual evaluation by a medical specialist.

Contraindications of VRILIGY

VRILIGY is contraindicated in case of allergy to dapoxetine, severe heart diseases, significant conduction disorders, or heart failure. The drug is not used in case of severe hepatic impairment, tendency to fainting, and certain psychiatric disorders in the medical history. An absolute restriction is the concomitant use of monoamine oxidase inhibitors, thioridazine, and a number of other serotonergic agents without a proper withdrawal period. Incompatible combinations can cause severe neurological and cardiovascular complications.

Caution is required in case of epilepsy, bleeding disorders, glaucoma, bipolar disorder, moderate renal impairment, and low blood pressure. Before prescribing, it is important to rule out orthostatic hypotension, in which blood pressure drops significantly when changing body position. Patients taking drugs for erectile dysfunction, alpha-blockers, or anticoagulants require particularly careful medical supervision. In case of severe renal impairment, use is usually not recommended.

VRILIGY is intended for adult men and is not used in children and adolescents under 18 years of age. The drug is not intended for women, including during pregnancy or breastfeeding. For men over 65 years of age, data on safety and efficacy are insufficient, so use requires an individual decision by a doctor. Age-related metabolic changes and concomitant diseases can increase the risk of side effects.

Interaction of VRILIGY with other drugs and alcohol

Dapoxetine must not be combined without medical supervision with antidepressants, monoamine oxidase inhibitors, tramadol, lithium, triptans, St. John's wort, and other substances that enhance serotonin transmission. Strong inhibitors of the CYP3A4 enzyme, in particular certain antifungal, antiviral, and antibacterial drugs, can significantly increase the concentration of dapoxetine. Caution is required with drugs to lower blood pressure, erectile dysfunction drugs, anticoagulants, and medicines that affect platelet function. A time interval determined by a doctor may be required between stopping some drugs and starting others.

Alcohol during the administration of VRILIGY must be avoided, as it increases dizziness, somnolence, impaired coordination, and the risk of fainting. Until individual tolerability is established, you must not drive a car, work at heights, or use dangerous machinery. Even in the absence of pronounced symptoms, reaction speed and concentration may deteriorate. If weakness, visual impairment, or instability occur, potentially dangerous activities must be postponed.

Where to buy VRILIGY in Ukraine

You can buy VRILIGY in Ukraine in pharmacies or through licensed pharmacy services if the drug is available for sale and its distribution complies with current regulations. Before ordering, you should check the integrity of the packaging, the manufacturer's name Centurion Laboratories, the 60 mg dosage, the batch number, and the expiration date. An excessively low price, lack of labeling, or sale from unverified sources may indicate a risk of falsification. Dispensing conditions and the need for a prescription must be clarified in accordance with current rules and doctor's recommendations.

VRILIGY should be stored in its original packaging, in a dry place protected from direct light and out of reach of children. The temperature regimen must comply with the manufacturer's instructions, and the tablets must not be used after the expiration date or if the blister is damaged. During delivery, it is important to avoid overheating, freezing, and excessive humidity. The information in the description does not replace medical consultation: before taking, you must consult a doctor, as efficacy and tolerability depend on the individual response of the body.